Issuer Free Writing Prospectus

Filed Pursuant to Rule 433

Registration Statement No. 333-114810

FINAL PRICING TERMS

May 1, 2007

 

 

 

Issuer:				Immunomedics, Inc. (NASDAQ: IMMU)
Securities Offered:				Common Stock
Maximum Number of Shares:				4,848,485
Price Per Share:				$4.95 per Share
Estimated net Proceeds:				$22,308,486

 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively the issuer and the placement agent will arrange to send you the prospectus if you request it by calling (212) 632-6717.